Alembic Pharmaceuticals informs about press release

25 Apr 2017 Evaluate

Alembic Pharmaceuticals has informed about press release titled ‘Alembic Pharmaceuticals receives USFDA Final Approvals for Olmesartan Medoxomil Tablets and Olmesartan Medoxomil with Hydrochlorothiazide Tablets’.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

699.05 -7.75 (-1.10%)
12-Mar-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.25
Dr. Reddys Lab 1321.45
Cipla 1333.50
Zydus Lifesciences 921.45
Lupin 2329.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×